These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 447799)

  • 21. Hypothalamic dysfunction in "cured" acromegaly is treatment modality dependent.
    Peacey SR; Toogood AA; Shalet SM
    J Clin Endocrinol Metab; 1998 May; 83(5):1682-6. PubMed ID: 9589676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conventional pituitary irradiation in acromegaly. Effect on growth hormone and TSH secretion.
    Lamberg BA; Kivikangas V; Vartianen J; Raitta C; Pelkonen R
    Acta Endocrinol (Copenh); 1976 Jun; 82(2):267-81. PubMed ID: 818860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy.
    Serri O; Somma M; Comtois R; Rasio E; Beauregard H; Jilwan N; Hardy J
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1185-9. PubMed ID: 4055986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
    Charalampaki P; Hildebrandt G; Schaeffer HJ; Schönau E; Klug N
    Exp Clin Endocrinol Diabetes; 1998; 106(2):130-4. PubMed ID: 9628244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.
    Gelato MC; Oldfield E; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1990 Sep; 71(3):585-90. PubMed ID: 2118536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly.
    Kim EH; Oh MC; Lee EJ; Kim SH
    Neurosurgery; 2012 May; 70(5):1106-13; discussion 1113. PubMed ID: 22067418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.
    Jallad RS; Musolino NR; Salgado LR; Bronstein MD
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):168-75. PubMed ID: 16060910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homocysteine levels in acromegaly patients.
    Hekimsoy Z; Ozmen B; Ulusoy S
    Neuro Endocrinol Lett; 2005 Dec; 26(6):811-4. PubMed ID: 16380700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid radioimmunoassay of plasma GH and its application to the judgement of surgical results in patients with acromegaly.
    Hanew K; Sato S; Sasaki A; Shimizu Y; Murakami O; Ikeda H; Katakura R; Niizuma H; Suzuki J; Yoshinaga K
    Tohoku J Exp Med; 1984 Aug; 143(4):467-71. PubMed ID: 6495325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly.
    Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Florimonte L; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 Jan; 84(1):17-23. PubMed ID: 9920056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly.
    Bianchi A; Giustina A; Cimino V; Pola R; Angelini F; Pontecorvi A; De Marinis L
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2015-22. PubMed ID: 19336510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perioperative plasma active and total ghrelin levels are reduced in acromegaly when compared with in nonfunctioning pituitary tumours even after normalization of serum GH.
    Kawamata T; Inui A; Hosoda H; Kangawa K; Hori T
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):140-4. PubMed ID: 17466003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Outcome of somatostatin analogue treatment in acromegaly].
    Mondok A; Tóth M; Patócs A; Szücs N; Igaz P; Pusztai P; Czirják S; Beko G; Gláz E; Rácz K; Tulassay Z
    Orv Hetil; 2009 Aug; 150(31):1457-62. PubMed ID: 19617182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression of cardiovascular disease in acromegalic patients treated by external pituitary irradiation.
    Baldwin A; Cundy T; Butler J; Timmis AD
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):26-30. PubMed ID: 3969807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
    Kreutzer J; Vance ML; Lopes MB; Laws ER
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4072-7. PubMed ID: 11549628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects of megavoltage radiotherapy in acromegaly.
    Lam KS; Wang C; Choi P; Ma JT; Yeung RT
    Aust N Z J Med; 1989 Jun; 19(3):202-6. PubMed ID: 2549927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effect of 90Y pituitary implantation in acromegaly.
    Jadresic A; Jimenez LE; Joplin GF
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):301-6. PubMed ID: 3618081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Size and erosive features of the sella turcica in acromegaly as predictors of therapeutic response to supervoltage irradiation.
    Dons RF; Rieth KG; Gorden P; Roth J
    Am J Med; 1983 Jan; 74(1):69-72. PubMed ID: 6849329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is soft tissue radiology useful in acromegaly?
    Paisey R; Jeans WD; Hartog M
    Br J Radiol; 1984 Jul; 57(679):561-4. PubMed ID: 6733402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.